Why the study?
Does high brachial-ankle pulse wave velocity predict major adverse cardiovascular events in patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention?
Does high brachial-ankle pulse wave velocity predict major adverse cardiovascular events in patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
High brachial-ankle pulse wave velocity is an independent predictor of major adverse cardiovascular events in patients with NSTEMI undergoing PCI, suggesting its utility for non-invasive risk stratification.
Objective Brachial-ankle pulse wave velocity (baPWV) measurement is a well-established modality for assessing arterial stiffness and predicting cardiovascular events. However, to our knowledge, its usefulness has not been clarified among patients with non-ST-elevation myocardial infarction (NSTEMI). This study assessed the prognostic value of baPWV in patients with NSTEMI. Patients and methods Patients (n=411, mean age, 63.8±13.5 years, 75.2% men) with NSTEMI who underwent a percutaneous coronary intervention and baPWV measurement were recruited between January 2013 and December 2015. Cardiac mortality and major adverse cardiovascular events (MACE) including cardiac death, re-acute myocardial infarction, revascularization, heart failure, and stroke after discharge were analyzed. The mean follow-up duration was 350 days. Results MACE and cardiac mortality occurred in 26 (6.3%) patients and 13 (3.1%) patients. Kaplan–Meier survival curves showed that MACE and cardiac mortality were significantly higher in patients with high baPWV (1708.0 cm/s). In multivariable Cox regression analysis, high baPWV (hazard ratio: 2.55; 95% confidence interval: 1.03–6.30, P=0.043) was an independent predictor of MACE even after adjusting for possible confounders. Conclusion Our findings indicate that baPWV was a strong independent prognostic factor of MACE in patients with NSTEMI. This suggests that baPWV can be a useful prognostic factor in the clinical setting for easier and less invasive prediction of MACE in patients with NSTEMI.
No takes yet. Share an insight, caveat, or question.
Park et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: